(Q44508238)

3 December 2017

title

Beta blockers in heart failure (English)

1 reference

3 December 2017

0 references

Henry J Dargie

1

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

3 December 2017

number of pages

2

1 reference

inferred from page(s)

published in

The Lancet

1 reference

3 December 2017

volume

362

1 reference

3 December 2017

issue

9377

1 reference

3 December 2017

page(s)

2-3

1 reference

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913842-1

7 January 2021

What type of beta-blocker should be used to treat chronic heart failure?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913842-1

7 January 2021

Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913842-1

7 January 2021

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913842-1

7 January 2021

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913842-1

7 January 2021

Effect of carvedilol on survival in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913842-1

7 January 2021

Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913842-1

7 January 2021

The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913842-1

7 January 2021

The heart failure revascularisation trial (HEART): rationale, design and methodology.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913842-1

7 January 2021

Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913842-1

7 January 2021

The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913842-1

7 January 2021

10.1016/S0140-6736(03)13842-1

Identifiers

DOI

1 reference

3 December 2017

1 reference